Rubella immunity status and the active offer of MMR/MMRV vaccination during pregnancy

Ann Ist Super Sanita. 2021 Jan-Mar;57(1):26-32. doi: 10.4415/ANN_21_01_04.

Abstract

Introduction: The rubella test during pregnancy makes it possible to identify situations at risk of congenital rubella and those pregnant mothers who should be offered the MMR vaccine.

Materials and methods: The Authors analysed test coverage and the immunity status of pregnant mothers between 2005 and 2017, using birth attendance certificates.

Results: Rubella test coverage on 61,437 pregnant mothers was 99.4%. The average proportion of susceptible subjects was 6.4%. Seroconversion was observed in 7 cases, with 1 confirmed case of congenital rubella. 32% of susceptible subjects were vaccinated, and adherence was seen to be influenced by the characteristics of the pregnant women and of the maternity unit.

Conclusions: A current information flow including a number of healthcare services, is useful both for monitoring the maternity care pathway and for public health purposes.

MeSH terms

  • Adolescent
  • Adult
  • Chickenpox Vaccine / immunology*
  • Female
  • Humans
  • Measles-Mumps-Rubella Vaccine / immunology*
  • Pregnancy
  • Pregnancy Complications, Infectious / prevention & control*
  • Retrospective Studies
  • Rubella / diagnosis*
  • Rubella / prevention & control*
  • Rubella Syndrome, Congenital / prevention & control*
  • Seroconversion
  • Vaccines, Combined / immunology
  • Young Adult

Substances

  • Chickenpox Vaccine
  • Measles-Mumps-Rubella Vaccine
  • Vaccines, Combined
  • measles, mumps, rubella, varicella vaccine